Skip to main content

Table 6 Predictors of adverse outcome, logistic regression analysis

From: Pyogenic brain abscess, a 15 year survey

Characteristic

Good outcome

Adverse outcome

Univariate

Multivariate, OR, 95% CI, p-value

 

GOS > 3, alive

GOS≤3/death

OR, 95% CI

 

Age, mean (SD)

45 (15.9)

52 (15.6)

1.03, 1.0-1.06

1.02,0.98-1.07, p=0.28

No predisposing factors

48

7 (13%)

3.5, 1.3-9.4

9.3, 1.6-54.7, p=0.014

Comorbidity

31

16 (34%)

  

GCS at presentation

    

 12-15

68

11(14%)

1.0

1.0

 8-11

7

3 (30%)

1.7, 0.6-12

3.5, 0.7-17.5, p=0.113

 <8

1

8 (89%)

26.5, 3.6-381

80.6, 2.5-2574, p=0.013

Burr hole aspiration

54 (79%)

14 (21%)

1.0

 

Craniotomy

17 (81%)

4 (19%)

0.9, 0.3-3.1

 

Medical

8 (62%)

5 (38%)

2.4, 0.7-8.5

 

Duration of symptoms before admission, days median (IQR)

4.0 (0–10)

3.0 (0–7)

0.99, 0.97-1.03

 

Time from admission to surgery, days median (IQR)

5.0 (1–13)

7.0 (1–14)

1.02, 0.97-1.07

 

Intraventricular rupture of brain abscess

4 (40%)

6 (60%)

6.6 ,1.7-26.2

11.5, 2.5-53.2, p=0.002

Meningitis*

20 (25%)

11 (48%)

2.7, 1.03-7.1

1.5, 0.3-6.3, p=0.597

Streptococcus species

45 (82%)

10 (18%)

  

Staphylococci

9 (60%)

6 (40%)

  

Gram-negative species

5 (83%)

1 (17%)

  

Anaerobic bacteria

7 (87%)

1 (13%)

  

Other

4 (100%)

0

  

Negative culture

9 (54%)

5 (36%)

  

Total n

79 (77%)

23 (23%)

  
  1. GOS: Glasgow Outcome score, GCS: Glasgow Coma Score, IQR: Inter quartile range. Bacterial species were omitted from logistic regression analysis due to limited number in each group and no significant difference in outcome in univariate analysis. *: Defined as positive spinal fluid culture and/or elevated CSF leukocytes (>15 cells/ μl).